Cell Impact AB (SE:CI)
:CI
Want to see SE:CI full AI Analyst Report?
Top Page
Cell Impact AB
(CI)
Select Model
Select Model
Rating:46Neutral
Price Target:
kr0.21
▼(-20.00% Downside)
Action:ReiteratedDate:04/25/26
The score is primarily constrained by deteriorating financial performance, marked by a sharp 2025 revenue drop, deeply negative profitability, and sustained cash burn with shrinking equity. Technicals provide some support due to strong momentum and price above key moving averages, but overbought readings temper that benefit. Valuation contributes only modestly because negative earnings make P/E less informative and there is no dividend yield data.
Positive Factors
Proprietary forming technology
Cell Impact's proprietary high‑velocity forming technology is a durable competitive asset in the hydrogen value chain. It creates technical barriers, supports differentiation on tooling and volume production, and underpins long-term supplier value to fuel cell and electrolyzer OEMs during industrialization and scale-up.
Negative Factors
Sharp revenue collapse
A steep drop in revenue dramatically reduces scale benefits and weakens customer diversification. The collapse undermines supply‑chain leverage and cost absorption, making profitable serial production harder to achieve and increasing the difficulty of recovering margins within a 2–6 month horizon.
Read all positive and negative factors
Positive Factors
Negative Factors
Proprietary forming technology
Cell Impact's proprietary high‑velocity forming technology is a durable competitive asset in the hydrogen value chain. It creates technical barriers, supports differentiation on tooling and volume production, and underpins long-term supplier value to fuel cell and electrolyzer OEMs during industrialization and scale-up.
Read all positive factors
Cell Impact AB (CI) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr129.03M
Dividend YieldN/A
Average Volume (3M)4.50M
Price to Earnings (P/E)―
Beta (1Y)1.04
Revenue Growth-85.08%
EPS Growth8.70%
CountrySE
Employees41
SectorIndustrials
Sector Strength72
IndustryManufacturing - Metal Fabrication
Share Statistics
EPS (TTM)-0.19
Shares Outstanding589,169,500
10 Day Avg. Volume6,494,872
30 Day Avg. Volume4,501,845
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.27
Price to Sales (P/S)5.83
P/FCF Ratio-0.69
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.48
Revenue Forecast (FY)kr40.00M
Cell Impact AB Business Overview & Revenue Model
Company Description
Cell Impact AB (CI) is a Swedish company specializing in the development and production of advanced fuel cell components, primarily focusing on bipolar plates for hydrogen fuel cells. The company operates within the renewable energy sector, aiming...
How the Company Makes Money
Cell Impact makes money primarily by selling flow plates to customers that manufacture fuel cell stacks and electrolyzers. Revenue is generated from (1) serial/volume production of formed flow plates delivered to customers for use in their product...
Cell Impact AB Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
48
Neutral
Cash Flow
18
Very Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.57M | 37.33M | 47.26M | 76.81M | 71.35M |
| Gross Profit | -121.42M | 5.42M | 25.45M | 36.94M | 34.88M |
| EBITDA | -55.03M | -66.52M | -97.72M | -86.22M | -68.84M |
| Net Income | -131.98M | -100.43M | -121.40M | -104.22M | -79.85M |
Balance Sheet | |||||
| Total Assets | 163.37M | 261.25M | 381.93M | 401.51M | 238.72M |
| Cash, Cash Equivalents and Short-Term Investments | 10.86M | 20.39M | 99.89M | 164.67M | 28.56M |
| Total Debt | 32.54M | 30.92M | 42.75M | 44.70M | 19.51M |
| Total Liabilities | 42.34M | 42.16M | 78.56M | 77.17M | 96.10M |
| Stockholders Equity | 121.03M | 219.08M | 303.37M | 324.35M | 142.63M |
Cash Flow | |||||
| Free Cash Flow | -47.29M | -76.66M | -152.75M | -174.32M | -140.39M |
| Operating Cash Flow | -45.36M | -62.23M | -100.97M | -105.93M | -86.08M |
| Investing Cash Flow | 2.30M | -14.43M | -51.78M | -68.40M | -54.32M |
| Financing Cash Flow | 33.68M | -2.84M | 88.09M | 310.47M | 17.01M |
Cell Impact AB Technical Analysis
Positive
0.26
Price Trends
0.13
Positive
0.18
Negative
0.19
Negative
Market Momentum
<0.01
Negative
68.13
Neutral
87.25
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:CI, the sentiment is Positive. The current price of 0.26 is above the 20-day moving average (MA) of 0.13, above the 50-day MA of 0.13, and above the 200-day MA of 0.19, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 68.13 is Neutral, neither overbought nor oversold. The STOCH value of 87.25 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:CI.
Cell Impact AB Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
53 Neutral | kr108.49M | -13.81 | -17.60% | ― | 58.33% | 80.04% | |
52 Neutral | kr1.28B | -6.93 | -7.30% | ― | 0.41% | -32.22% | |
46 Neutral | kr129.03M | -0.25 | ― | ― | -85.08% | 8.70% | |
44 Neutral | kr66.97M | 40.79 | -110.39% | ― | 13.02% | 29.29% | |
44 Neutral | kr932.03M | -12.66 | -39.97% | ― | 10.26% | -1.53% | |
41 Neutral | kr210.25M | -0.70 | 0.35% | ― | 4.48% | -1231.05% |
* Industrials Sector Average
SE:CI
Cell Impact AB
0.22
-0.17
-44.22%
SE:PCELL
PowerCell Sweden AB
22.16
-2.84
-11.36%
SE:AXOLOT
Axolot Solutions Holding AB
0.34
-0.08
-19.62%
SE:TRANS
Transtema Group AB
4.91
-9.74
-66.50%
SE:BOMILL
BoMill AB
0.46
-0.33
-41.48%
SE:SALT.B
SaltX Technology Holding AB Class B
3.92
-0.66
-14.46%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.